Ligufalimab, a novel anti-CD47 antibody with no hemagglutination demonstrates both monotherapy and combo antitumor activity
===========================================================================================================================

* Tailong Qu
* Tingting Zhong
* Xinghua Pang
* Zhaoliang Huang
* Chunshan Jin
* Zhongmin Maxwell Wang
* Baiyong Li
* Yu Xia